| 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 妇科类(元) | 286,644,014.63 | - | 290,644,912.63 |
| 抗肿瘤类(元) | 612,257,835.90 | - | 1,231,944,248.38 |
| 心脑血管类(元) | 245,198,338.53 | - | 283,169,754.93 |
| 医疗服务(元) | 466,655,584.69 | 230,776,300.00 | 458,063,738.09 |
| 医药工业板块(元) | - | 924,822,400.00 | - |
| 其他(元) | 539,408,151.95 | - | 544,288,658.05 |
| 营业成本(元) | |||
| 妇科类(元) | 121,638,707.28 | - | 115,558,830.35 |
| 抗肿瘤类(元) | 71,155,780.33 | - | 128,117,018.97 |
| 心脑血管类(元) | 92,258,782.19 | - | 84,865,608.85 |
| 医疗服务(元) | 364,551,655.66 | - | 348,935,183.75 |
| 医药工业板块(元) | - | - | - |
| 其他(元) | 170,604,970.99 | - | 178,064,595.43 |
| 毛利(元) | |||
| 妇科类(元) | 165,005,307.35 | - | 175,086,082.28 |
| 抗肿瘤类(元) | 541,102,055.57 | - | 1,103,827,229.41 |
| 心脑血管类(元) | 152,939,556.34 | - | 198,304,146.08 |
| 医疗服务(元) | 102,103,929.03 | - | 109,128,554.34 |
| 医药工业板块(元) | - | - | - |
| 其他(元) | 368,803,180.96 | - | 366,224,062.62 |
| 毛利率(%) | |||
| 妇科类(%) | 57.56 | - | 60.24 |
| 抗肿瘤类(%) | 88.38 | - | 89.60 |
| 心脑血管类(%) | 62.37 | - | 70.03 |
| 医疗服务(%) | 21.88 | - | 23.82 |
| 医药工业板块(%) | - | - | - |
| 其他(%) | 68.37 | - | 67.28 |
| 收入构成(%) | |||
| 妇科类(%) | 13.33 | - | 10.35 |
| 抗肿瘤类(%) | 28.47 | - | 43.87 |
| 心脑血管类(%) | 11.40 | - | 10.08 |
| 医疗服务(%) | 21.70 | 19.97 | 16.31 |
| 医药工业板块(%) | - | 80.03 | - |
| 其他(%) | 25.09 | - | 19.38 |
| 毛利构成(%) | |||
| 妇科类(%) | 12.41 | - | 8.97 |
| 抗肿瘤类(%) | 40.69 | - | 56.53 |
| 心脑血管类(%) | 11.50 | - | 10.16 |
| 医疗服务(%) | 7.68 | - | 5.59 |
| 医药工业板块(%) | - | - | - |
| 其他(%) | 27.73 | - | 18.76 |